MoneyWorks4Me

Syncom Formulations (India) informs about board meeting

02 Nov 2019 Evaluate

With Reference to Regulation 29(1)(a) of SEBI (LODR) Regulations, 2015, Syncom Formulations (India) has informed that 3/2019-20 Meeting of the Board of directors of the Company is scheduled to be held on Thursday 14th November, 2019 at 4:00 PM at the Corporate office of the Company to consider and adopt the Standalone Unaudited Financial Results along with Limited Review Report by the Auditors of the company for the Half Year/ Quarter ended on 30th September, 2019 alongwith Statement of Assets and Liabilities and Statement of Cash Flow. 

The above information is a part of company’s filings submitted to BSE.

Syncom Formulations Share Price

13.44 0.25 (1.90%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: